EER review is single-anonymized: the referee sees who the authors are. The referee is typically an expert in your exact design or field and frequently someone you cite. Two gates precede them: an editor desk-screen (out-of-scope or low-novelty papers are rejected without review, and the submission fee is non-refundable), then ≥2 external referees for an independent assessment (检索于 2026-06;以官网为准). The first decision is usually fast; the strategic move is to pre-empt the predictable objections in the paper itself so a referee has less to grab.
| Likely objection | Pre-emption (where it lives) |
|---|---|
| "Not general interest / too narrow" | breadth hook on page one (eer-topic-selection, eer-writing-style) |
| "Contribution is incremental / already known" | named frontier delta + concurrent-work distinction (eer-literature-positioning) |
| "Identification is not credible" | design-appropriate estimator + key-assumption defense (eer-identification) |
| "TWFE is biased here" | heterogeneity-robust DiD + flat leads (eer-identification) |
| "Exclusion restriction is assumed, not defended" | theory + institutions + falsification (eer-identification) |
| "Result is fragile / spec-dependent" | coefficient-stability battery (eer-robustness) |
| "Inference ignores clustering/dependence" | correct clustering + wild bootstrap / dependence-robust SEs (eer-robustness) |
| "Model is decorative" | model delivers the tested comparative static (eer-theory-model) |
| "Can't reproduce this" | replication package ready + data statement (eer-replication-package) |
| "Exhibits unreadable / stars instead of SEs" | one headline table with SEs (eer-tables-figures) |
A finance paper anticipates three objections: (1) "endogenous treatment" → adds an IV with a defended exclusion and a placebo; (2) "driven by the crisis years" → leave-out-period robustness in-text; (3) "incremental vs. paper X" → a sentence naming exactly how it relaxes X's key assumption. All three are answered in the submitted paper. When the report arrives, the referee's main asks are already addressed, shortening the R&R.
【Likely referee profile】field/design expert; possibly cited author
【Top 3 objections】each + where pre-empted in the paper
【Desk-screen risk】breadth/novelty visible up front? [Y/N]
【Pre-built defenses】identification/robustness/replication ready? [Y/N]
【Claim calibration】matched to evidence? [Y/N]
【Next step】eer-submission (preflight) → eer-rebuttal (after decision)